In mid-2019, sensationalized headlines dominated global news cycles with terrifying stories of a mysterious, life-threatening lung disease emerging in the United States. Dubbed EVALI, this condition was quickly weaponized by anti-vaping advocates to call for sweeping bans on electronic cigarettes. However, behind the media panic lies a clear, scientifically proven truth that separates illicit street drugs from regulated smoking cessation tools.
To understand the reality of EVALI, we must look at the timeline of the outbreak, the chemical differences between black-market THC cartridges and commercial nicotine e-liquids, and the stark contrast in regulatory frameworks between the United States and Europe.
What is EVALI:
EVALI (e-cigarette or vaping product use-associated lung injury) is a severe lung inflammation caused by inhaling harmful vaping substances. Due to the wide variety of illicit, counterfeit, and unregulated vaping ingredients, EVALI presents differently in patients, commonly manifesting as pneumonia, alveolar (air sac) damage, or acute fibrinous pneumonitis.
The Rise and Fall of the 2019 EVALI Outbreak
The EVALI crisis began in April 2019 when young, seemingly healthy individuals in the US Midwest began presenting to hospitals with severe respiratory distress. Patients reported a rapid onset of symptoms, including:
- Respiratory distress: Severe shortness of breath, persistent coughing, and chest pain.
- Gastrointestinal issues: Nausea, vomiting, diarrhea, and abdominal cramping.
- Systemic symptoms: High fever, chills, fatigue, and rapid weight loss.
By September 2019, the outbreak had reached its peak. The Centers for Disease Control and Prevention (CDC) eventually recorded over 2,800 hospitalizations and 68 deaths. Because the symptoms closely mirrored severe infectious pneumonia, clinicians struggled to identify the cause, ultimately categorizing it as a “diagnosis of exclusion.” This meant that if a patient vaped and had lung damage with no infectious cause, it was labeled EVALI.
This broad definition allowed anti-vaping groups to blame commercial nicotine e-cigarettes. However, as the CDC and FDA dug deeper, a common thread emerged: the vast majority of patients were using their devices to inhale tetrahydrocannabinol (THC), the psychoactive compound in cannabis.
Vitamin E Acetate: The Smoking Gun
The breakthrough in the investigation came when researchers analyzed bronchoalveolar lavage (BAL) fluid—fluid washed from the lungs – of EVALI patients. The laboratory results were definitive: Vitamin E acetate was present in nearly every sample.
Vitamin E acetate is a synthetic oil-based compound. While perfectly safe when ingested as a dietary supplement or applied to the skin in cosmetics, it behaves catastrophically when heated and inhaled. Once vaporized, it reverts to an oily state inside the lungs, coating the delicate alveoli (air sacs), triggering massive inflammatory responses, and preventing oxygen absorption.
This oily thickener was used by illicit, black-market manufacturers to dilute expensive THC oil in order to maximize profits. It was never used in commercially manufactured nicotine e-liquids. Nicotine e-liquids are water-soluble formulations consisting of propylene glycol (PG), vegetable glycerin (VG), and water-soluble flavorings. If an oil like Vitamin E acetate were added to a standard nicotine e-liquid, it would immediately separate, making the product visibly ruined and unusable.
| Feature | Regulated Nicotine E-Liquids | Illicit THC Vape Cartridges (2019 Outbreak) |
|---|---|---|
| Primary Carrier | Propylene Glycol (PG) & Vegetable Glycerin (VG) | THC Oil / Medium-Chain Triglyceride (MCT) Oil |
| Thickening Agents | None (Water-soluble) | Vitamin E Acetate (Oil-based) |
| Solubility | Water-soluble | Fat-soluble (Lipophilic) |
| EVALI Association | No association established | Directly responsible for 94%+ of cases |
| Regulation | Strictly tested by MHRA / ANSES | Unregulated, sold via informal/black-market channels |
StagBar Vape 6in1 180K Puffs Disposable
The Stagbar 6-in-1 featuring a unique 6-flavor system and six independent mesh coils, this device allows users to switch between six distinct tastes in one sleek unit, delivering an unprecedented 180,000 puffs.
Why EVALI Was an American Phenomenon
One of the most telling pieces of evidence regarding EVALI is its geography. Despite there being an estimated 60 to 90 million nicotine vapers worldwide, the EVALI outbreak was almost entirely localized to the United States.
In the United Kingdom and the European Union, the vaping industry is governed by the Tobacco Products Directive (TPD) and the Tobacco and Related Products Regulations (TRPR). These frameworks enforce some of the strictest quality and safety standards in the world. Under these laws:
- All e-cigarette products must be submitted to the UK Medicines and Healthcare products Regulatory Agency (MHRA) with detailed ingredient profiles before they can be sold.
- Ingredients known to pose inhalation risks, including Vitamin E acetate and diacetyl, are strictly banned.
- Maximal nicotine concentrations and bottle sizes are strictly capped.
Because of these preemptive safety measures, Public Health England confirmed that there was no corresponding lung disease outbreak in the UK. Regulated nicotine vaping continued to be endorsed by health bodies as a vital tool to help smokers transition away from combustible tobacco.
Debunking Common Vaping Misconceptions
The media sensationalism surrounding EVALI breathed new life into several long-standing myths about vaping. Let us examine the scientific facts behind the most common misconceptions.
Myth 1: Vaping is just as harmful as smoking
This is flatly contradicted by chemical science. Traditional cigarette smoke contains over 7,000 chemicals, at least 70 of which are known carcinogens. Because vaping does not involve combustion, it produces no tar and no carbon monoxide – the two most destructive elements of tobacco smoke. Independent reviews by health authorities consistently show that vaping carries only a fraction of the risk of smoking.
Myth 2: Vaping causes “Popcorn Lung”
Popcorn lung (bronchiolitis obliterans) is a rare inflammatory lung condition historically linked to diacetyl, a chemical once used as a buttery flavoring agent in microwave popcorn factories. While diacetyl was briefly used in early e-liquid formulations over a decade ago, it has been legally banned in UK and EU e-liquids since 2016. Furthermore, there has never been a single documented case of popcorn lung caused by commercial vaping.
- Read more:
Myth 3: Nicotine is the primary cause of smoking-related cancers
While nicotine is highly addictive and keeps people smoking, it is not the substance that causes cancer. The Royal Society for Public Health (RSPH) compares nicotine’s safety profile to caffeine. The real danger of smoking lies in the toxic metals, poisonous gases, and tar generated by burning tobacco leaf, none of which are present in clean nicotine vapor.
Myth 4: Secondhand vapor poses severe health risks to bystanders
Unlike secondhand tobacco smoke, which lingers in enclosed spaces and contains highly concentrated toxins, exhaled vape aerosol is fundamentally different. Studies show that e-cigarette vapor dissipates within seconds. International health reports indicate that nicotine and solvent residues in rooms where vaping occurs are negligible and fall well below dangerous exposure thresholds.
The Financial and Practical Reality of Swapping to Stop
Beyond the immense health benefits of quitting smoking, the financial incentives of switching to a regulated pod or cigalike system are substantial. Combustible cigarettes are heavily taxed, making them a significant financial burden compared to vaping.
| Timeframe | Smoker (1 Pack/Day) | Vaper (Regulated Pod System) | Approximate Savings |
|---|---|---|---|
| 1 Month | £360+ | £50 – £80 | ~£300 Saved |
| 1 Year | £4,320+ | £600 – £960 | ~£3,400 Saved |
For smokers looking to quit, clinical evidence supports vaping as a premier tool. A comprehensive study by the highly respected Cochrane Collaboration confirmed that nicotine e-cigarettes are significantly more effective at helping people quit smoking than traditional nicotine replacement therapies (NRTs) like patches or nicotine gum. This efficacy is why the NHS actively promotes its “Swap to Stop” scheme, aiming to transition one million smokers to vaping.
The Bottom Line
EVALI was a tragic, localized public health crisis caused by unregulated, illicit THC products cut with Vitamin E acetate. It was not, and has never been, an inherent risk of vaping legal, regulated nicotine e-liquids.
For adult smokers seeking to reclaim their health, allowing misinformation about EVALI to deter a quit attempt is a dangerous mistake. By sourcing high-quality, fully compliant products from reputable retailers, vapers can rest assured that their transition away from combustible tobacco is backed by rigorous safety standards and sound medical science.
